🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Efficacy of Hemostatic Agents

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma NCT07284758Phase 260 sites📍 Huntsville📍 Phoenix📍 Scottsdale C4 Therapeutics, Inc. · Tests: Cemsidomide, Dexamethasone Universal CAR-T Cell Therapy for MM NCT07248176NA1 site📍 Shanghai Bioray Laboratories · Tests: Targeted BCMA Gene-Modified Allogeneic Chimeric Antigen Receptor T-Cell Injection A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments NCT05714839Phase 1, Phase 244 sites📍 Bullhead City📍 Los Angeles📍 Pembroke Pines GlaxoSmithKline · Tests: Belantamab, Belantamab mafodotin, Pomalidomide, Dexamethasone A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma NCT07760454Phase 1, Phase 22 sites📍 Suzhou📍 Shanghai UCARsgen Biotech Limited · Tests: CT0596 Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia NCT05640102n/a8 sites📍 Huntsville📍 Mobile📍 Duarte BeiGene · Tests: Zanubrutinib A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study NCT06271252Phase 11 site📍 Atlanta OriCell Therapeutics Co., Ltd. · Tests: OriCAR-017 A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant NCT05623020Phase 3180 sites📍 Daphne📍 Daphne📍 Fairhope Pfizer · Tests: Elranatamab, Daratumumab, Lenalidomide, Dexamethasone, Bortezomib Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma NCT07333430Phase 11 site📍 Jerusalem Hadassah Medical Organization · Tests: Naive HBI0101 CAR-T A Clinical Study of SHR-9539 in Patients With Multiple Myeloma NCT06484777Phase 11 site📍 Chengdu Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-9539 for injection Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma NCT06461988Phase 21 site📍 Palo Alto Stanford University · Tests: Talquetamab, Talquetamab and Lenalidomide A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma. NCT06232096Phase 1, Phase 21 site📍 Beijing Beijing Mabworks Biotech Co., Ltd. · Tests: MBS314 Injection A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea NCT06698887n/a5 sites📍 Hwasun📍 Seoul📍 Seoul Bristol-Myers Squibb · Tests: Idecabtagene vicleucel Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research NCT07085559EARLY Phase 11 site📍 Hefei Anhui Provincial Hospital · Tests: Metabolically Armed BCMA CAR-T cells. Study of Ravulizumab in Pediatric Participants With Primary IgAN NCT07024563Phase 315 sites📍 Palo Alto📍 Aurora📍 Beijing Alexion Pharmaceuticals, Inc. · Tests: Ravulizumab A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM) NCT06953960Phase 1, Phase 251 sites📍 Los Angeles📍 New Haven📍 Boston AbbVie · Tests: Surzetoclax, Daratumumab, Dexamethasone, Pomalidomide, Etentamig To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma NCT07454187Phase 1, Phase 24 sites📍 Zhengzhou📍 Suzhou📍 Xi’an Hangzhou Sumgen Biotech Co., Ltd. · Tests: SG2918 A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma NCT07582432Phase 35 sites📍 St. Petersburg📍 Fort Wayne📍 Westbrook Grifols Biologicals, LLC · Tests: Gamunex-C, 10% Injectable Solution Survivors Uniting for Remote Guided Exercise NCT07290309NA1 site📍 Fort Collins Colorado State University · Tests: Virtually Supervised Exercise Sessions, Asynchronous Group A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). NCT07638683Phase 21 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Teclistamab A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma NCT06121843Phase 119 sites📍 Birmingham📍 Phoenix📍 Duarte Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Tests: BMS-986393, Alnuctamab, Mezigdomide, Iberdomide, Elranatamab Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA NCT07620275Phase 13 sites📍 Beijing📍 Beijing📍 Tianjin Chinese PLA General Hospital · Tests: KSVCBD injection DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib PPI Supplementation to Fight ECtopIc Calcification in PXE NCT04868578NA2 sites📍 Angers📍 Nice Centre Hospitalier Universitaire de Nice · Tests: study treatment PPI, Placebo comparator A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma NCT06574568Phase 112 sites📍 Beijing📍 Beijing📍 Foshan Excyte Biopharma Ltd · Tests: YKST02 Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma NCT07555938Phase 393 sites📍 Duarte📍 Irvine📍 New Haven Hoffmann-La Roche · Tests: Cevostamab, Pomalidomide, Dexamethasone, Daratumumab, Elotuzumab A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma NCT07579234Phase 31 site📍 Tianjing Shandong New Time Pharmaceutical Co., LTD · Tests: F182112 single-agent, Pomalidomide + Bortezomib + Dexamethasone (PVd) or Selinexor + Bortezomib + Dexamethasone (SVd) APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma NCT04657861EARLY Phase 11 site📍 Hangzhou Zhejiang University · Tests: APRIL CAR-T cells Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia NCT05099471Phase 214 sites📍 Bielefeld📍 Chemnitz📍 Kempten Christian Buske · Tests: Venetoclax; Rituximab, DRC Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function NCT04643106NA2 sites📍 Goyang-si📍 Seoul Seoul National University Hospital · Tests: Hemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy, suturing with barbed sutures during lapa… Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma NCT05565807Phase 1, Phase 24 sites📍 Beijing📍 Beijing📍 Guangzhou Zhejiang ACEA Pharmaceutical Co. Ltd. · Tests: STI-6129
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy